EF
ZBH icon

Empirical Finance’s Zimmer Biomet ZBH Stock Holding History

Empirical Finance’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$633K Buy
7,357
+227
+3% +$19.9K 0.03% 401
2026
Q1 		$645K Sell
7,130
-14
-0.2% -$1.28K 0.03% 373
2025
Q4 		$642K Sell
7,144
-311
-4% -$29.5K 0.03% 371
2025
Q3 		$734K Buy
7,455
+68
+0.9% +$6.74K 0.04% 370
2025
Q2 		$674K Buy
7,387
+46
+0.6% +$4.45K 0.04% 375
2025
Q1 		$831K Buy
7,341
+239
+3% +$25.6K 0.05% 309
2024
Q4 		$750K Sell
7,102
-78
-1% -$8.37K 0.04% 327
2024
Q3 		$775K Buy
7,180
+156
+2% +$17K 0.05% 323
2024
Q2 		$762K Sell
7,024
-487
-6% -$57.4K 0.05% 316
2024
Q1 		$991K Buy
7,511
+255
+4% +$31.9K 0.06% 278
2023
Q4 		$883K Buy
7,256
+59
+0.8% +$6.58K 0.06% 281
2023
Q3 		$808K Buy
7,197
+659
+10% +$83.7K 0.06% 280
2023
Q2 		$952K Buy
6,538
+729
+13% +$99.1K 0.07% 246
2023
Q1 		$751K Buy
5,809
+321
+6% +$40.3K 0.07% 270
2022
Q4 		$700K Buy
5,488
+436
+9% +$50.6K 0.07% 269
2022
Q3 		$528K Buy
5,052
+835
+20% +$91.6K 0.06% 288
2022
Q2 		$443K Buy
4,217
+228
+6% +$27.1K 0.06% 300
2022
Q1 		$510K Buy
3,989
+325
+9% +$39.2K 0.06% 303
2021
Q4 		$452K Buy
3,664
+989
+37% +$129K 0.05% 327
2021
Q3 		$380K Buy
2,675
+154
+6% +$22.7K 0.06% 307
2021
Q2 		$394K Buy
2,521
+360
+17% +$58.3K 0.06% 283
2021
Q1 		$323K Hold
2,161
– – 0.06% 252
2020
Q4 		$323K Buy
2,161
+381
+21% +$53.8K 0.06% 252
2020
Q3 		$235K Buy
+1,780
New +$233K 0.05% 252
2017
Q1 		– Sell
-76
Closed -$8K – 595
2016
Q4 		$8K Buy
+76
New +$8.15K 0.01% 442

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Empirical Finance's ZBH Position: Q2 2026 in Review

Empirical Finance increased its Zimmer Biomet (ZBH) stake by 3.2% in Q2 2026, buying an estimated $19.9K and bringing the position to 7,357 shares worth $633K. The position accounts for 0.03% of the portfolio, ranked #401.

Empirical Finance first reported a position in ZBH in Q4 2016 and has held it in 25 quarters since. The position peaked at $991K in Q1 2024. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Empirical Finance held 7,357 shares of Zimmer Biomet worth $633K as of Q2 2026.
  • Empirical Finance bought 227 Zimmer Biomet shares in Q2 2026, an estimated $19.9K.
  • Zimmer Biomet made up 0.03% of Empirical Finance's portfolio in Q2 2026, its #401 holding.
  • Empirical Finance first reported a position in Zimmer Biomet in Q4 2016 and has held it in 25 quarters since.
  • Empirical Finance's Zimmer Biomet position peaked at $991K in Q1 2024.
  • 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Empirical Finance's 13F filing for Q2 2026, filed 14 Aug 2026.